Bloomberg Businessweek

Pfizer’s Second Gut Punch Shows Pitfalls of Weight-Loss Pills

Dec 1, 2023
Guest
Amy Stillman
Guest
Benjamin Wolkon
Guest
Cory Klippsten
Guest
Madison Muller
Pfizer's weight-loss setback warns of challenges in the obesity market. Crypto outlook for 2024 and climate funding investment discussed. Chinese car sales dominance in Mexico detailed. Market activities and uncertainty looming in November. Technology's impact and sponsor ads featured.
Ask episode
Chapters
Transcript
Episode notes
1
Introduction
00:00 • 2min
2
Pharmaceutical Companies and Weight Loss Pills
01:31 • 7min
3
The Unforeseen Effects of Weight-Loss Pills on Industries
08:39 • 2min
4
Bitcoin's Rise and Potential Impact of ETF Approval
10:46 • 8min
5
Crypto Concerns and Climate Food Solutions
18:51 • 17min
6
Market Activities and Uncertainty in November
35:28 • 7min
7
Discussion on Technology and a Sponsor Ad
42:28 • 3min